{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:27:14Z","timestamp":1790011634250,"version":"4.0.1"},"reference-count":335,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:00:00Z","timestamp":1674950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002949","name":"Jiangsu Provincial Health and Family Planning Commission","doi-asserted-by":"publisher","award":["ZDXKB2016020"],"award-info":[{"award-number":["ZDXKB2016020"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Hematologic malignancies (HMs) mainly include acute and chronic leukemia, lymphoma, myeloma and other heterogeneous tumors that seriously threaten human life and health. The common effective treatments are radiotherapy, chemotherapy and hematopoietic stem cell transplantation (HSCT), which have limited options and are prone to tumor recurrence and (or) drug resistance. Metformin is the first-line drug for the treatment of type 2 diabetes (T2DM). Recently, studies identified the potential anti-cancer ability of metformin in both T2DM patients and patients that are non-diabetic. The latest epidemiological and preclinical studies suggested a potential benefit of metformin in the prevention and treatment of patients with HM. The mechanism may involve the activation of the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway by metformin as well as other AMPK-independent pathways to exert anti-cancer properties. In addition, combining current conventional anti-cancer drugs with metformin may improve the efficacy and reduce adverse drug reactions. Therefore, metformin can also be used as an adjuvant therapeutic agent for HM. This paper highlights the anti-hyperglycemic effects and potential anti-cancer effects of metformin, and also compiles the in vitro and clinical trials of metformin as an anti-cancer and chemosensitizing agent for the treatment of HM. The need for future research on the use of metformin in the treatment of HM is indicated.<\/jats:p>","DOI":"10.3390\/biom13020250","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T04:58:25Z","timestamp":1675054705000},"page":"250","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-9519","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaheng","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Liu, J., Bell, C., Campbell, V., DeBacker, J., Tamberg, E., Lee, C., and Mehta, S. (2017). Noninvasive Ventilation in Patients With Hematologic Malignancy. J. Intensive Care Med., 885066617690725.","DOI":"10.1177\/0885066617690725"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/atm.ATM_21_17","article-title":"Characteristics and predictors of mortality of patients with hematologic malignancies requiring invasive mechanical ventilation","volume":"12","author":"Tlayjeh","year":"2017","journal-title":"Ann. Thorac. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"112747","DOI":"10.1016\/j.biopha.2022.112747","article-title":"Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism","volume":"148","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1182\/blood.2022015789","article-title":"CAR T cells as a second-line therapy for large B-cell lymphoma: A paradigm shift?","volume":"139","author":"Westin","year":"2022","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5021983","DOI":"10.1155\/2020\/5021983","article-title":"\u03b2-Phenethyl Isothiocyanate Induces Cell Death in Human Osteosarcoma through Altering Iron Metabolism, Disturbing the Redox Balance, and Activating the MAPK Signaling Pathway","volume":"2020","author":"Lv","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"World Health Organization (2022, November 02). Model List of Essential Medicines. 22nd List. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02.","DOI":"10.1530\/ey.19.13.1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/M15-2650","article-title":"Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis","volume":"164","author":"Maruthur","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/dom.12267","article-title":"The prognostic value of metformin for cancer patients with concurrent diabetes: A systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: A meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Noto, H., Goto, A., Tsujimoto, T., and Noda, M. (2012). Cancer risk in diabetic patients treated with metformin: A systematic review and meta-analysis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033411"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G.F., Pellegrini, F., and Nicolucci, A. (2013). Metformin therapy and risk of cancer in patients with type 2 diabetes: Systematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071583"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: A systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1634\/theoncologist.2013-0111","article-title":"Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: A systematic review and meta-analysis","volume":"18","author":"Yin","year":"2013","journal-title":"Oncologist"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/dmrr.2645","article-title":"Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: Evidence from a meta-analysis","volume":"31","author":"Deng","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/pcan.2014.52","article-title":"Impact of metformin on clinical outcomes among men with prostate cancer: A systematic review and meta-analysis","volume":"18","author":"Raval","year":"2015","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/br.2015.417","article-title":"Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis","volume":"3","author":"Zhu","year":"2015","journal-title":"Biomed. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1940-6207.CAPR-14-0291","article-title":"Metformin use and lung cancer risk in patients with diabetes","volume":"8","author":"Sakoda","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/rccm.201407-1395OC","article-title":"Survival of patients with stage IV lung cancer with diabetes treated with metformin","volume":"191","author":"Lin","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hed.23409","article-title":"Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma","volume":"36","author":"Sandulache","year":"2014","journal-title":"Head Neck"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/hed.23743","article-title":"Effect of metformin on the incidence of head and neck cancer in diabetics","volume":"37","author":"Yen","year":"2015","journal-title":"Head Neck"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: A meta-analysis and critical literature review","volume":"135","author":"Col","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1634\/theoncologist.2015-0096","article-title":"Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis","volume":"20","author":"Xu","year":"2015","journal-title":"Oncologist"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diabres.2014.04.007","article-title":"Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"106","author":"Wang","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1245\/s10434-015-5028-8","article-title":"Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer","volume":"23","author":"Fransgaard","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mei, Z.B., Zhang, Z.J., Liu, C.Y., Liu, Y., Cui, A., Liang, Z.L., Wang, G.H., and Cui, L. (2014). Survival benefits of metformin for colorectal cancer patients with diabetes: A systematic review and meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091818"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/IGC.0b013e3182a80a21","article-title":"The effects of metformin on ovarian cancer: A systematic review","volume":"23","author":"Dilokthornsakul","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/AOG.0b013e3182393ab3","article-title":"Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity","volume":"119","author":"Romero","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.27706","article-title":"Metformin intake is associated with better survival in ovarian cancer: A case-control study","volume":"119","author":"Kumar","year":"2013","journal-title":"Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1210\/jc.2012-1267","article-title":"Metformin for liver cancer prevention in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"66202","DOI":"10.18632\/oncotarget.11033","article-title":"Metformin use improves survival of diabetic liver cancer patients: Systematic review and meta-analysis","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: Historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9258(18)86579-6","article-title":"Studies in the metabolism changes induced by administration of guanidine bases: I. Influence of injected guanidine hydrochloride upon blood sugar content","volume":"33","author":"Watanabe","year":"1918","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1039\/CT9222101790","article-title":"CCXIV.\u2014The preparation of methylguanidine, and of \u03b2\u03b2-dimethylguanidine by the interaction of dicyanodiamide, and methylammonium and dimethylammonium chlorides respectively","volume":"121","author":"Werner","year":"1922","journal-title":"J. Chem. Soc. Trans."},{"key":"ref_38","first-page":"233","article-title":"Metformin: The past, presence, and future","volume":"106","author":"Paluch","year":"2015","journal-title":"Minerva Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","article-title":"The UK prospective diabetes study (UKPDS): Clinical and therapeutic implications for type 2 diabetes","volume":"48","author":"King","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin: An old but still the best treatment for type 2 diabetes","volume":"5","author":"Rojas","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Agius, L., Ford, B.E., and Chachra, S.S. (2020). The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093240"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"509714","DOI":"10.3389\/fpubh.2020.509714","article-title":"Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer","volume":"8","author":"Jones","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_43","first-page":"658","article-title":"Metformin: Current knowledge","volume":"19","author":"Nasri","year":"2014","journal-title":"J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1573399811666150325233108","article-title":"Molecular action of metformin in hepatocytes: An updated insight","volume":"11","author":"Sliwinska","year":"2015","journal-title":"Curr. Diabetes Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00125-006-0141-7","article-title":"Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: A systematic review","volume":"49","author":"Natali","year":"2006","journal-title":"Diabetologia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrendo.2017.80","article-title":"Regulation of hepatic glucose metabolism in health and disease","volume":"13","author":"Petersen","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.12659\/MSM.911250","article-title":"Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK\/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress","volume":"25","author":"Zhao","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhou, J., Massey, S., Story, D., and Li, L. (2018). Metformin: An Old Drug with New Applications. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102863"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3109\/10428194.2014.922180","article-title":"Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin","volume":"56","author":"Adekola","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/jdi.12864","article-title":"Mechanisms of metformin action: In and out of the gut","volume":"9","author":"Minamii","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fendo.2018.00372","article-title":"Metabolic Profiles Associated With Metformin Efficacy in Cancer","volume":"9","author":"Andrzejewski","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"Nogueira","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","article-title":"Targeting cancer metabolism: A therapeutic window opens","volume":"10","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmet.2016.09.003","article-title":"Metformin Activates AMPK through the Lysosomal Pathway","volume":"24","author":"Zhang","year":"2016","journal-title":"Cell Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1","volume":"71","author":"Regazzetti","year":"2011","journal-title":"Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in cellular energy homeostasis and drug targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10408398.2010.500245","article-title":"Cross-talk between AMPK and mTOR in regulating energy balance","volume":"52","author":"Xu","year":"2012","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/db13-0670","article-title":"Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob\/ob mice","volume":"63","author":"Jiang","year":"2014","journal-title":"Diabetes"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2013.37.1.1","article-title":"AMPK and exercise: Glucose uptake and insulin sensitivity","volume":"37","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nat. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/BJ20150125","article-title":"Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity","volume":"468","author":"Ford","year":"2015","journal-title":"Biochem. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","article-title":"AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development","volume":"28","author":"Boudaba","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: An overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: From mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.932600","article-title":"Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties","volume":"63","author":"Drahota","year":"2014","journal-title":"Physiol. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.M110.121806","article-title":"Metformin activates AMP kinase through inhibition of AMP deaminase","volume":"286","author":"Ouyang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4161\/cc.26461","article-title":"Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer","volume":"12","author":"Marini","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/srep02070","article-title":"Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II","volume":"3","author":"Salani","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.18632\/aging.101004","article-title":"Biological and biophysics aspects of metformin-induced effects: Cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates","volume":"8","author":"Picone","year":"2016","journal-title":"Aging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"730048","DOI":"10.3389\/fphys.2021.730048","article-title":"Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?","volume":"12","author":"Anand","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e2122287119","DOI":"10.1073\/pnas.2122287119","article-title":"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis","volume":"119","author":"LaMoia","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/0973-1482.151444","article-title":"Combined therapeutic effect and molecular mechanisms of metformin and cisplatin in human lung cancer xenografts in nude mice","volume":"11","author":"Chen","year":"2015","journal-title":"J. Cancer Res. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1111\/jcmm.14194","article-title":"Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells","volume":"23","author":"Lee","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/cam4.1133","article-title":"Metformin synergistic pemetrexed suppresses non-small-cell lung cancer cell proliferation and invasion in vitro","volume":"6","author":"Zhang","year":"2017","journal-title":"Cancer Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.2147\/CMAR.S200059","article-title":"The beneficial effects of metformin on cancer prevention and therapy: A comprehensive review of recent advances","volume":"11","author":"Saraei","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabres.2018.05.023","article-title":"Metformin in cancer","volume":"143","author":"Mallik","year":"2018","journal-title":"Diabetes Res. Clin. Pr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.seminoncol.2015.09.009","article-title":"Repurposing old drugs to chemoprevention: The case of metformin","volume":"43","author":"Gandini","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/s41375-019-0470-4","article-title":"Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells","volume":"33","author":"Mishra","year":"2019","journal-title":"Leukemia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/cas.13523","article-title":"Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma","volume":"109","author":"Sekino","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.cell.2012.07.032","article-title":"Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1","volume":"150","author":"Schweitzer","year":"2012","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.1232044","article-title":"A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1","volume":"340","author":"Chantranupong","year":"2013","journal-title":"Science"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: From molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cellsig.2016.03.009","article-title":"AMPK\/Snf1 signaling regulates histone acetylation: Impact on gene expression and epigenetic functions","volume":"28","author":"Salminen","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"39939","DOI":"10.18632\/oncotarget.17829","article-title":"Metformin induces protein acetylation in cancer cells","volume":"8","author":"Vancura","year":"2017","journal-title":"Oncotarget"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1038\/srep05810","article-title":"Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation","volume":"4","author":"Hu","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2014Mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.18632\/oncotarget.13639","article-title":"Anti-tumor activity of metformin: From metabolic and epigenetic perspectives","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1515\/hsz-2017-0271","article-title":"Metformin-induced anticancer activities: Recent insights","volume":"399","author":"Safe","year":"2018","journal-title":"Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"27692","DOI":"10.1074\/jbc.M114.592576","article-title":"Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: Role of specificity protein (Sp) transcription factors","volume":"289","author":"Nair","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/cas.13083","article-title":"Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway","volume":"107","author":"Zou","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2014.11.028","article-title":"Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a","volume":"121","author":"Akamine","year":"2015","journal-title":"Life Sci."},{"key":"ref_107","first-page":"2845","article-title":"Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK\/p53\/miR-23a\/FOXA1 pathway","volume":"9","author":"Sun","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41419-018-0336-0","article-title":"Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy","volume":"9","author":"Celestini","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Grossi, V., Fasano, C., Celestini, V., Lepore Signorile, M., Sanese, P., and Simone, C. (2019). Chasing the Foxo3: Insights into its new mitochondrial lair in colorectal cancer landscape. Cancers, 11.","DOI":"10.3390\/cancers11030414"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","article-title":"The biology of YAP\/TAZ: Hippo signaling and beyond","volume":"94","author":"Piccolo","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/13813455.2020.1760304","article-title":"The effects of metformin on the hippo pathway in the proliferation of melanoma cancer cells: A preclinical study","volume":"128","author":"Sajedianfard","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1111\/jcmm.15241","article-title":"Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-019-1503-6","article-title":"Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis","volume":"39","author":"Jin","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s13046-019-1346-1","article-title":"Metformin targets a YAP1-TEAD4 complex via AMPK\u03b1 to regulate CCNE1\/2 in bladder cancer cells","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopha.2018.03.031","article-title":"Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity","volume":"102","author":"Yuan","year":"2018","journal-title":"Biomed. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"46230","DOI":"10.18632\/oncotarget.10079","article-title":"Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP","volume":"7","author":"Tian","year":"2016","journal-title":"Oncotarget"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-016-3037-3","article-title":"Combinational strategies of metformin and chemotherapy in cancers","volume":"78","author":"Zhang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_119","first-page":"Cd012160","article-title":"PI3K\/AKT\/mTOR inhibitors for advanced or recurrent endometrial cancer","volume":"10","author":"Roncolato","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4161\/cbt.5.10.3162","article-title":"Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines","volume":"5","author":"Liu","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"21631","DOI":"10.1074\/jbc.M300609200","article-title":"NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4","volume":"278","author":"Helbig","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/carcin\/bgu001","article-title":"Paradoxic effects of metformin on endothelial cells and angiogenesis","volume":"35","author":"Dallaglio","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13046-020-01627-6","article-title":"Metformin inhibits cervical cancer cell proliferation by modulating PI3K\/Akt-induced major histocompatibility complex class I-related chain A gene expression","volume":"39","author":"Xia","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"C4","DOI":"10.1152\/ajpcell.00296.2011","article-title":"A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells","volume":"303","author":"Nelson","year":"2012","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4252\/wjsc.v12.i12.1455","article-title":"Effect of metformin on stem cells: Molecular mechanism and clinical prospect","volume":"12","author":"Jiang","year":"2020","journal-title":"World J. Stem Cells"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/onc.2012.181","article-title":"Targeting metabolism for cancer treatment and prevention: Metformin, an old drug with multi-faceted effects","volume":"32","author":"Pierotti","year":"2013","journal-title":"Oncogene"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1158\/0008-5472.CAN-17-2460","article-title":"Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e02242","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"elife"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"873","DOI":"10.18632\/oncotarget.6418","article-title":"Metformin suppresses hypoxia-induced stabilization of HIF-1\u03b1 through reprogramming of oxygen metabolism in hepatocellular carcinoma","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_132","first-page":"3501","article-title":"Metformin suppresses hypoxia-induced migration via the HIF-1\u03b1\/VEGF pathway in gallbladder cancer in vitro and in vivo","volume":"40","author":"Ye","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41590-020-0666-9","article-title":"Regulatory myeloid cells paralyze T cells through cell\u2013cell transfer of the metabolite methylglyoxal","volume":"21","author":"Baumann","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/intimm\/dxy079","article-title":"Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: Implications for metabolic reprogramming of myeloid cells and anti-tumor effects","volume":"31","author":"Uehara","year":"2019","journal-title":"Int. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"109458","DOI":"10.1016\/j.biopha.2019.109458","article-title":"Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice","volume":"120","author":"Xu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1022939318102","article-title":"The hypoxic tumour microenvironment and metastatic progression","volume":"20","author":"Subarsky","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/ijo.2014.2441","article-title":"Lipogenesis in cancer progression","volume":"45","author":"Mounier","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"22162","DOI":"10.1016\/S0021-9258(17)31770-2","article-title":"Critical phosphorylation sites for acetyl-CoA carboxylase activity","volume":"269","author":"Ha","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1038\/cddis.2011.86","article-title":"Metformin inhibits melanoma development through autophagy and apoptosis mechanisms","volume":"2","author":"Tomic","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.4103\/jcrt.jcrt_1824_21","article-title":"A new contribution for an old drug: Prospect of metformin in colorectal oncotherapy","volume":"17","author":"Jiang","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1038\/cddis.2014.59","article-title":"Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling","volume":"5","author":"Feng","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/0008-5472.CAN-08-2689","article-title":"Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation","volume":"69","author":"Saito","year":"2009","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41421-018-0033-2","article-title":"Cancer cell specific inhibition of Wnt\/\u03b2-catenin signaling by forced intracellular acidification","volume":"4","author":"Melnik","year":"2018","journal-title":"Cell Discov."},{"key":"ref_146","first-page":"2030","article-title":"Metformin-induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)-like inhibitory protein through a caspase-dependent pathway in human renal cell carcinoma A498 cells","volume":"16","author":"Jang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.7150\/jca.36372","article-title":"Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks","volume":"11","author":"Zhao","year":"2020","journal-title":"J. Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fendo.2019.00294","article-title":"Role of mitochondria in the mechanism (s) of action of metformin","volume":"10","author":"Vial","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Saladini, S., Aventaggiato, M., Barreca, F., Morgante, E., Sansone, L., Russo, M.A., and Tafani, M. (2019). Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells. Cells, 8.","DOI":"10.3390\/cells8010049"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/1878-0261.12384","article-title":"Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling","volume":"12","author":"Shen","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40880-017-0184-9","article-title":"Metformin targets multiple signaling pathways in cancer","volume":"36","author":"Lei","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ncomms1859","article-title":"Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC","volume":"3","author":"Blandino","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/celldisc.2017.22","article-title":"Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities","volume":"3","author":"Pulito","year":"2017","journal-title":"Cell Discov."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Cabello, P., Pineda, B., Tormo, E., Lluch, A., and Eroles, P. (2016). The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081298"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3892\/or.2015.4496","article-title":"The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin","volume":"35","author":"Kato","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10637-017-0508-2","article-title":"Crucial microRNAs and genes in metformin\u2019s anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis","volume":"36","author":"Li","year":"2018","journal-title":"Investig. New Drugs"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2014.08.154","article-title":"Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: Involvement of the tumor suppressor miR30a and its target gene SOX4","volume":"452","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000441011","article-title":"Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression","volume":"96","author":"Kalogirou","year":"2016","journal-title":"Urol. Int."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3892\/or.2015.4284","article-title":"Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies","volume":"34","author":"Fujimori","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.18632\/oncotarget.3063","article-title":"Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/ijo.2017.3971","article-title":"Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma","volume":"50","author":"Chiyo","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3892\/mmr.2016.5143","article-title":"Metformin induces apoptosis by microRNA-26a-mediated downregulation of myeloid cell leukaemia-1 in human oral cancer cells","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2018.01.007","article-title":"Metformin: Prevention of genomic instability and cancer: A review","volume":"827","author":"Najafi","year":"2018","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","article-title":"Metformin inhibits P-glycoprotein expression via the NF-\u03baB pathway and CRE transcriptional activity through AMPK activation","volume":"162","author":"Kim","year":"2011","journal-title":"Br. J. Pharm."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_166","first-page":"309","article-title":"Uber den stoffwechsel der karzinomezellen","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem Z"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbrc.2003.11.136","article-title":"Cancer metabolism: Facts, fantasy, and fiction","volume":"313","author":"Zu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1038\/s41598-017-05052-2","article-title":"The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells","volume":"7","author":"Loubiere","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.3390\/cancers14133220","article-title":"The Mechanism of Action of Biguanides: New Answers to a Complex Question","volume":"14","author":"Bordone","year":"2022","journal-title":"Cancers"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","article-title":"Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation","volume":"134","author":"Huang","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"20348","DOI":"10.1074\/jbc.M115.662114","article-title":"Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1\u03b2 (IL-1\u03b2) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages","volume":"290","author":"Kelly","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: Response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_176","first-page":"4885","article-title":"Mechanisms of metformin inhibiting cancer invasion and migration","volume":"12","author":"Chen","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Hsu, S.K., Cheng, K.C., Mgbeahuruike, M.O., Lin, Y.H., Wu, C.Y., Wang, H.D., Yen, C.H., Chiu, C.C., and Sheu, S.J. (2021). New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179453"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1111\/cas.14124","article-title":"Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer","volume":"110","author":"Park","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.18632\/oncotarget.6748","article-title":"Negative regulation of Bmi-1 by AMPK and implication in cancer progression","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Kang, S., Kim, B.R., Kang, M.H., Kim, D.Y., Lee, D.H., Oh, S.C., Min, B.W., and Um, J.W. (2018). Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205449"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Huang, H. (2018). Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors, 18.","DOI":"10.3390\/s18103249"},{"key":"ref_182","first-page":"e28086","article-title":"The involvement of JAK-STAT3 in cell motility, invasion, and metastasis","volume":"3","author":"Teng","year":"2014","journal-title":"Jakstat"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1073\/pnas.1221055110","article-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","volume":"110","author":"Hirsch","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3892\/or.2015.4191","article-title":"Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models","volume":"34","author":"Jun","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"73892","DOI":"10.18632\/oncotarget.18029","article-title":"Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-019-1211-2","article-title":"Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_187","first-page":"8732","article-title":"Morphoproteomics identifies constitutive activation of the mTORC2\/Akt and NF-\u03baB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: Pathogenetic implications and therapeutic options","volume":"7","author":"Quesada","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3109\/10428194.2011.574752","article-title":"Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma","volume":"52","author":"Koo","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: A population-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428194.2016.1236375","article-title":"Impact of metformin on the progression of MGUS to multiple myeloma","volume":"58","author":"Boursi","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.canlet.2014.09.050","article-title":"Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models","volume":"356","author":"Zi","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2014.307","article-title":"The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma","volume":"111","author":"Wu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic metformin\/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/leu.2015.157","article-title":"Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib","volume":"29","author":"Jagannathan","year":"2015","journal-title":"Leukemia"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"215582","DOI":"10.1016\/j.canlet.2022.215582","article-title":"Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells","volume":"532","author":"You","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.7150\/jca.60208","article-title":"Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia","volume":"12","author":"Zhou","year":"2021","journal-title":"J. Cancer"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"101301","DOI":"10.1016\/j.tranon.2021.101301","article-title":"The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo","volume":"15","author":"Morris","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Arnason, T.G., MacDonald-Dickinson, V., Gaunt, M.C., Davies, G.F., Lobanova, L., Trost, B., Gillespie, Z.E., Waldner, M., Baldwin, P., and Borrowman, D. (2022). Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma. Cancers, 14.","DOI":"10.3390\/cancers14174215"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"117276","DOI":"10.1016\/j.lfs.2020.117276","article-title":"Inhibition of mTORC1\/P70S6K pathway by Metformin synergistically sensitizes Acute Myeloid Leukemia to Ara-C","volume":"243","author":"Yuan","year":"2020","journal-title":"Life Sci."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40170-020-00213-w","article-title":"Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma","volume":"8","author":"Singh","year":"2020","journal-title":"Cancer Metab."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-018-0731-5","article-title":"Metformin induces autophagy and G0\/G1 phase cell cycle arrest in myeloma by targeting the AMPK\/mTORC1 and mTORC2 pathways","volume":"37","author":"Wang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","article-title":"Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin","volume":"21","author":"Bajpai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2013.04.015","article-title":"The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL\/T-LL cancer cells","volume":"336","author":"Rosilio","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"867133","DOI":"10.3389\/fphar.2022.867133","article-title":"Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells","volume":"13","author":"Glamoclija","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Liu, L., Patnana, P.K., Xie, X., Frank, D., Nimmagadda, S.C., Rosemann, A., Liebmann, M., Klotz, L., Opalka, B., and Khandanpour, C. (2022). High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL\/AF9 Acute Myeloid Leukemia. Cancers, 14.","DOI":"10.3390\/cancers14030486"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"112140","DOI":"10.1016\/j.biopha.2021.112140","article-title":"Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation","volume":"143","author":"Saber","year":"2021","journal-title":"Biomed. Pharm."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Valiulien\u0117, G., Vitkevi\u010dien\u0117, A., Skliut\u0117, G., Borutinskait\u0117, V., and Navakauskien\u0117, R. (2021). Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling. Molecules, 26.","DOI":"10.3390\/molecules26082303"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.3904\/kjim.2019.336","article-title":"Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells","volume":"36","author":"Na","year":"2021","journal-title":"Korean J. Intern. Med."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"106383","DOI":"10.1016\/j.leukres.2020.106383","article-title":"Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase","volume":"94","author":"Saito","year":"2020","journal-title":"Leuk. Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jphs.2019.10.003","article-title":"Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest","volume":"141","author":"Zhou","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/mc.23092","article-title":"Oxidative phosphorylation inhibition induces anticancerous changes in therapy-resistant-acute myeloid leukemia patient cells","volume":"58","author":"Janulis","year":"2019","journal-title":"Mol. Carcinog."},{"key":"ref_212","first-page":"1387","article-title":"Effect of Metformin on Proliferation Capacity, Apoptosis and Glycolysis in K562 Cells","volume":"27","author":"Chen","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3389\/fphar.2018.01258","article-title":"Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells","volume":"9","author":"Renner","year":"2018","journal-title":"Front. Pharm."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.gene.2018.01.017","article-title":"Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line","volume":"647","author":"Asik","year":"2018","journal-title":"Gene"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/jcp.26085","article-title":"Concentration-dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells","volume":"233","author":"Ravera","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jphs.2017.08.003","article-title":"Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells","volume":"135","author":"Liang","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.7150\/jca.19873","article-title":"Metformin Sensitizes Leukemia Cells to Vincristine via Activation of AMP-activated Protein Kinase","volume":"8","author":"Yi","year":"2017","journal-title":"J. Cancer"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.leukres.2016.10.004","article-title":"Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine","volume":"50","author":"Sabnis","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"51435","DOI":"10.18632\/oncotarget.9843","article-title":"Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport","volume":"7","author":"Velez","year":"2016","journal-title":"Oncotarget"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"18965","DOI":"10.18632\/oncotarget.7879","article-title":"Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1","volume":"7","author":"Voltan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.leukres.2015.09.016","article-title":"Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy","volume":"39","author":"Wang","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/CAD.0000000000000266","article-title":"The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell","volume":"26","author":"Shi","year":"2015","journal-title":"Anti-Cancer Drugs"},{"key":"ref_223","first-page":"516460","article-title":"Metformin Induces Cell Cycle Arrest and Apoptosis in Drug-Resistant Leukemia Cells","volume":"2015","author":"Boyano","year":"2015","journal-title":"Leuk. Res. Treat."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3892\/mmr.2014.2629","article-title":"Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines","volume":"10","author":"Zhang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Leclerc, G.M., Leclerc, G.J., Kuznetsov, J.N., DeSalvo, J., and Barredo, J.C. (2013). Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074420"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbrc.2012.05.001","article-title":"Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK\/ERK signaling pathway","volume":"422","author":"Huai","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"885011","DOI":"10.3389\/fonc.2022.885011","article-title":"Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC\/BCL2 double expressor lymphoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"661102","DOI":"10.3389\/fonc.2021.661102","article-title":"Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma","volume":"11","author":"Bagaloni","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41375-018-0305-8","article-title":"Blood and skin-derived Sezary cells: Differences in proliferation-index, activation of PI3K\/AKT\/mTORC1 pathway and its prognostic relevance","volume":"33","author":"Cristofoletti","year":"2019","journal-title":"Leukemia"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"21166","DOI":"10.18632\/oncotarget.24989","article-title":"Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells","volume":"9","author":"Chukkapalli","year":"2018","journal-title":"Oncotarget"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cellsig.2017.09.020","article-title":"Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation","volume":"40","author":"Granato","year":"2017","journal-title":"Cell. Signal."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Schlesser, C., Meul, T., Stathopoulos, G., and Meiners, S. (2022). Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib. Biomolecules, 12.","DOI":"10.3390\/biom12060756"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5114\/aoms.2020.101305","article-title":"The mechanism of treatment of multiple myeloma with metformin by way of metabolism","volume":"17","author":"Song","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s43440-020-00142-x","article-title":"Influence of metformin on HIF-1 pathway in multiple myeloma","volume":"72","author":"Trojan","year":"2020","journal-title":"Pharm. Rep."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2019.05.136","article-title":"The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3","volume":"515","author":"Liu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_236","first-page":"489","article-title":"Metformin Induces Apoptosis of Human Multiple Myeloma Cell U266 through the Mitochondrial Apoptotic Pathway","volume":"26","author":"Tong","year":"2018","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1159\/000491908","article-title":"Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells","volume":"48","author":"Zhao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_238","first-page":"1097","article-title":"Effect of Metformin on Proliferation of Multiple Myeloma Cells","volume":"25","author":"Lu","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukaemia","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1182\/blood-2010-02-269837","article-title":"The LKB1\/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/14728222.2012.694869","article-title":"Targeting the liver kinase B1\/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies","volume":"16","author":"Martelli","year":"2012","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2014.01.006","article-title":"Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia","volume":"346","author":"Rosilio","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_243","first-page":"1322","article-title":"Effect of metformin on acute promyelocytic leukemia cell line NB4 and its mechanism","volume":"20","author":"Huai","year":"2012","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/jrpp.JRPP_17_37","article-title":"Missing the benefit of metformin in acute myeloid leukemia: A problem of contrast?","volume":"6","author":"Ceacareanu","year":"2017","journal-title":"J. Res. Pharm. Pract."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1101\/SQB.1986.051.01.104","article-title":"Oncogene activation by chromosomal translocation in chronic myelocytic leukemia","volume":"51","author":"Groffen","year":"1986","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_246","first-page":"3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"BLOOD-NEW YORK"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1182\/blood-2011-01-332783","article-title":"Antileukemic effects of AMPK activators on BCR-ABL-expressing cells","volume":"118","author":"Vakana","year":"2011","journal-title":"Blood"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/10781552221077254","article-title":"Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia","volume":"28","author":"Pokorny","year":"2022","journal-title":"J. Oncol. Pharm. Pr."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.blre.2010.09.004","article-title":"Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia","volume":"25","author":"Paganin","year":"2011","journal-title":"Blood Rev."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nri2304","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma","volume":"8","author":"Aifantis","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/leu.2011.269","article-title":"AMP-dependent kinase\/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: Therapeutic implications","volume":"26","author":"Grimaldi","year":"2012","journal-title":"Leukemia"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4161\/cc.20770","article-title":"Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells","volume":"11","author":"Pan","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ncb2037","article-title":"Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia","volume":"12","author":"Mavrakis","year":"2010","journal-title":"Nat. Cell. Biol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.yjmcc.2008.10.008","article-title":"Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts","volume":"46","author":"Mayr","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1242\/jcs.201954","article-title":"Retraction: Oncogene PKC\u03b5 controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2","volume":"130","author":"Niture","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-10-40","article-title":"LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription","volume":"10","author":"Tang","year":"2013","journal-title":"Retrovirology"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc1592","article-title":"Leukaemia stem cells and the evolution of cancer-stem-cell research","volume":"5","author":"Huntly","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","article-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","volume":"71","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12967-018-1620-6","article-title":"Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene","volume":"16","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"e27224","DOI":"10.1002\/pbc.27224","article-title":"A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin","volume":"65","author":"Trucco","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clml.2012.05.004","article-title":"A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia","volume":"12","author":"Vu","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_262","first-page":"270","article-title":"Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment","volume":"52","year":"2014","journal-title":"Rev. M\u00e9dica Inst. Mex. Seguro Soc."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MPH.0b013e31829cdeba","article-title":"Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia","volume":"35","author":"Bostrom","year":"2013","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"22624","DOI":"10.18632\/oncotarget.4168","article-title":"Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells","volume":"6","author":"Bruno","year":"2015","journal-title":"Oncotarget"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2013-02-484386","article-title":"Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia","volume":"122","author":"Yaktapour","year":"2013","journal-title":"Blood"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1158\/0008-5472.CAN-09-4411","article-title":"Modifying akt signaling in B-cell chronic lymphocytic leukemia cells","volume":"70","author":"Hofbauer","year":"2010","journal-title":"Cancer Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3324\/haematol.2009.010272","article-title":"Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: The therapeutic potential of Akt inhibition","volume":"95","author":"Zhuang","year":"2010","journal-title":"Haematologica"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1541-7786.MCR-10-0559","article-title":"STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells","volume":"9","author":"Liu","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1038\/onc.2012.546","article-title":"Essential role of cooperative NF-\u03baB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma","volume":"32","author":"Kesanakurti","year":"2013","journal-title":"Oncogene"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737","volume":"117","author":"Brown","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/asheducation-2015.1.272","article-title":"Evolving diagnostic criteria for multiple myeloma","volume":"2015","author":"Rajkumar","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/pros.23235","article-title":"Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells","volume":"76","author":"Garcia","year":"2016","journal-title":"Prostate"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1182\/blood-2012-03-417253","article-title":"Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium","volume":"120","author":"Birmann","year":"2012","journal-title":"Blood"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"e1633235","DOI":"10.1080\/2162402X.2019.1633235","article-title":"Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy","volume":"8","author":"Verdura","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1182\/blood-2011-09-380410","article-title":"Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/leu.2013.76","article-title":"The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis","volume":"27","author":"Kocemba","year":"2013","journal-title":"Leukemia"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/leu.2010.193","article-title":"Low bone marrow oxygen tension and hypoxia-inducible factor-1\u03b1 overexpression characterize patients with multiple myeloma: Role on the transcriptional and proangiogenic profiles of CD138(+) cells","volume":"24","author":"Colla","year":"2010","journal-title":"Leukemia"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/leu.2013.24","article-title":"Hypoxia-inducible factor (HIF)-1\u03b1 suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction","volume":"27","author":"Storti","year":"2013","journal-title":"Leukemia"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Tyszka-Czochara, M., Bukowska-Strakova, K., Kocemba-Pilarczyk, K.A., and Majka, M. (2018). Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1\u03b1-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines. Nutrients, 10.","DOI":"10.3390\/nu10070841"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"55057","DOI":"10.18632\/oncotarget.10842","article-title":"Metformin increases PDH and suppresses HIF-1\u03b1 under hypoxic conditions and induces cell death in oral squamous cell carcinoma","volume":"7","author":"Farias","year":"2016","journal-title":"Oncotarget"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.avsg.2022.04.035","article-title":"Metformin Inhibits Multiple Myeloma Serum-induced Endothelial Cell Thrombosis by Down-Regulating miR-532","volume":"85","author":"Gao","year":"2022","journal-title":"Ann. Vasc. Surg."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000505992","article-title":"The Association between Metabolic Syndrome and Multiple Myeloma","volume":"144","author":"Ragbourne","year":"2021","journal-title":"Acta Haematol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajh.24355","article-title":"Reappraisal of risk factors for monoclonal gammopathy of undetermined significance","volume":"91","author":"Boursi","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1874467211666180830150546","article-title":"The Role of SAPK\/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells","volume":"11","author":"Naserian","year":"2018","journal-title":"Curr. Mol. Pharm."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann. Oncol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"608238","DOI":"10.3389\/fonc.2021.608238","article-title":"Alteration of Cholesterol Metabolism by Metformin Is Associated With Improved Outcome in Type II Diabetic Patients With Diffuse Large B-Cell Lymphoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.beha.2018.07.013","article-title":"Burkitt lymphoma- a rare but challenging lymphoma","volume":"31","author":"Casulo","year":"2018","journal-title":"Best Pr. Res. Clin. Haematol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/bjh.15997","article-title":"Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma","volume":"186","author":"Wang","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/1055-9965.EPI-18-0012","article-title":"Metformin Is Not Associated with Incidence Risk of Non-Hodgkin Lymphomas among Diabetic Patients","volume":"27","author":"Ye","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bjh.16635","article-title":"Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: A large population-based study of 4913 subjects","volume":"191","author":"Smyth","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.diabet.2019.05.002","article-title":"Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes","volume":"45","author":"Tseng","year":"2019","journal-title":"Diabetes Metab."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjms.2019.06.002","article-title":"Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma","volume":"358","author":"Wynn","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood.V122.21.1825.1825","article-title":"Metformin lowers the mitochondrial potential of lymphoma cells and its use during front-line rituximab-based chemo-immunotherapy improves the clinical outcome of diffuse Large B-cell lymphoma","volume":"122","author":"Singh","year":"2013","journal-title":"Blood"},{"key":"ref_300","first-page":"4","article-title":"Metformin prolonged the survival of diffuse large B-cell lymphoma and grade 3b follicular lymphoma patients responding to first-line treatment with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone: A prospective phase II clinical trial","volume":"2018","author":"Fan","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2337\/dc18-2182","article-title":"Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study","volume":"42","author":"Dawed","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"952560","DOI":"10.3389\/fphar.2022.952560","article-title":"The effects of metformin in the treatment of osteoarthritis: Current perspectives","volume":"13","author":"Song","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00125-017-4343-y","article-title":"60 years of metformin use: A glance at the past and a look to the future","volume":"60","author":"Marshall","year":"2017","journal-title":"Diabetologia"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/jc.2015-3754","article-title":"Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study","volume":"101","author":"Aroda","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"e17918","DOI":"10.1097\/MD.0000000000017918","article-title":"Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/archinte.166.18.1975","article-title":"Risk factors of vitamin B(12) deficiency in patients receiving metformin","volume":"166","author":"Ting","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2337\/diacare.23.9.1227","article-title":"Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin","volume":"23","author":"Bauman","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2147\/DDDT.S141675","article-title":"Metformin: A review of its potential indications","volume":"11","author":"Wang","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/dme.13098","article-title":"Lactic acidosis: Relationship between metformin levels, lactate concentration and mortality","volume":"33","author":"Ropers","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/15563650.2013.784774","article-title":"Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs","volume":"51","author":"Hayashi","year":"2013","journal-title":"Clin. Toxicol."},{"key":"ref_312","first-page":"Cd002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"2010","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2019.01.002","article-title":"SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes","volume":"846","author":"Donnan","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Ahmad, E., Sargeant, J.A., Zaccardi, F., Khunti, K., Webb, D.R., and Davies, M.J. (2020). Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120427"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"b1668","DOI":"10.1136\/bmj.b1668","article-title":"Newer agents for blood glucose control in type 2 diabetes: Summary of NICE guidance","volume":"338","author":"Adler","year":"2009","journal-title":"BMJ"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5694\/mja2.50239","article-title":"Metformin: Time to review its role and safety in chronic kidney disease","volume":"211","author":"Tanner","year":"2019","journal-title":"Med. J. Aust."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/M21-4389","article-title":"Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study","volume":"175","author":"Wensink","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_318","first-page":"4757","article-title":"Potential mechanisms of metformin-induced memory impairment","volume":"25","author":"Alhowail","year":"2021","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0885066618793385","article-title":"Review of Biguanide (Metformin) Toxicity","volume":"34","author":"Wang","year":"2019","journal-title":"J. Intensive Care Med."},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"(2022). Update on metformin safety in pregnancy. Drug Ther. Bull., 60, 99.","DOI":"10.1136\/dtb.2022.000032"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10815-022-02429-9","article-title":"The use of metformin in women with polycystic ovary syndrome: An updated review","volume":"39","author":"Notaro","year":"2022","journal-title":"J Assist Reprod. Genet."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"784459","DOI":"10.3389\/fphar.2022.784459","article-title":"Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin","volume":"13","author":"Bailey","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"659723","DOI":"10.1155\/2013\/659723","article-title":"Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy","volume":"2013","author":"Ferro","year":"2013","journal-title":"Int. J. Breast Cancer"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1574884713666181025141559","article-title":"Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization","volume":"14","author":"Mortezaee","year":"2019","journal-title":"Curr. Clin. Pharm."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fonc.2019.00247","article-title":"A Novel Mechanism of High Dose Radiation Sensitization by Metformin","volume":"9","author":"Brown","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/dc14-0500","article-title":"Metformin and cancer: Mounting evidence against an association","volume":"37","author":"Suissa","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.2337\/dc13-1489","article-title":"Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas","volume":"37","author":"Mamtani","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: The end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ctrv.2018.08.004","article-title":"Challenges and perspectives in the treatment of diabetes associated breast cancer","volume":"70","author":"Samuel","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"548436","DOI":"10.1155\/2015\/548436","article-title":"Recent advances in the use of metformin: Can treating diabetes prevent breast cancer?","volume":"2015","author":"Hatoum","year":"2015","journal-title":"Biomed. Res. Int"},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Samuel, S.M., Varghese, E., Kubatka, P., Triggle, C.R., and B\u00fcsselberg, D. (2019). Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer. Biomolecules, 9.","DOI":"10.3390\/biom9120846"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/iub.1481","article-title":"The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling","volume":"68","author":"Scherbakov","year":"2016","journal-title":"IUBMB Life"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyx046","article-title":"Metformin and cancer in type 2 diabetes: A systematic review and comprehensive bias evaluation","volume":"46","author":"Farmer","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","article-title":"Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3\u03b2-MCL-1 Axis","volume":"35","author":"Elgendy","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/2\/250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:18:55Z","timestamp":1760120335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/2\/250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,29]]},"references-count":335,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["biom13020250"],"URL":"https:\/\/doi.org\/10.3390\/biom13020250","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,29]]}}}